INR 910.0
(-0.9%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 711.88 Million INR | 0.0% |
2022 | 692.39 Million INR | -23.35% |
2021 | 903.37 Million INR | 58.83% |
2020 | 568.78 Million INR | 87.03% |
2019 | 304.11 Million INR | -5.8% |
2018 | 322.82 Million INR | 119.84% |
2017 | 146.84 Million INR | 215.1% |
2016 | 46.6 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 271.99 Million INR | 28.29% |
2024 Q1 | 212.02 Million INR | 2.87% |
2023 Q3 | 202.4 Million INR | 22.8% |
2023 Q4 | 206.1 Million INR | 1.83% |
2023 FY | 692.4 Million INR | 0.0% |
2023 Q1 | 156.3 Million INR | -39.45% |
2023 Q2 | 164.82 Million INR | 5.45% |
2022 Q1 | 154.24 Million INR | -13.49% |
2022 Q4 | 258.15 Million INR | 28.78% |
2022 FY | 692.39 Million INR | -23.35% |
2022 Q3 | 200.46 Million INR | -8.77% |
2022 Q2 | 219.74 Million INR | 42.47% |
2021 Q1 | 347.68 Million INR | 46.22% |
2021 FY | 903.37 Million INR | 58.83% |
2021 Q4 | 178.3 Million INR | -7.96% |
2021 Q3 | 193.73 Million INR | -10.33% |
2021 Q2 | 216.04 Million INR | -37.86% |
2020 FY | 568.78 Million INR | 87.03% |
2020 Q4 | 237.78 Million INR | 0.0% |
2019 FY | 304.11 Million INR | -5.8% |
2019 Q4 | 91.57 Million INR | 0.0% |
2018 FY | 322.82 Million INR | 119.84% |
2017 FY | 146.84 Million INR | 215.1% |
2016 FY | 46.6 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Dr. Lal PathLabs Limited | 8.65 Billion INR | 91.775% |
Metropolis Healthcare Limited | 2.05 Billion INR | 65.365% |
Thyrocare Technologies Limited | 917 Million INR | 22.369% |
Vijaya Diagnostic Centre Limited | 3.62 Billion INR | 80.381% |
Vimta Labs Limited | 1.22 Billion INR | 41.998% |